Indonesia is attractive, thanks to its healthcare reforms and relaxation of foreign ownership, while Vietnam has emerged as a booming market, according to CEO Prem Kumar Nair.
“We get a lot of patients from Vietnam into our Singapore operations,” he said in an interview in Kuala Lumpur this week.
The company currently operates more than 80 hospitals in 10 countries, including Singapore, India and China, and has been actively acquiring healthcare facilities in recent years.
It bought Island Hospital Sdn Bhd in Malaysia in 2024.
Its Turkish unit, Acibadem and Indian affiliate Fortis Healthcare also purchased hospitals in their respective markets in the last two years.
The company has US$14 billion in market capitalisation and is the most valuable listed hospital operator in Southeast Asia.
The desire to widen expansion in the region comes as IHH looks to make up for rising import costs in the industry.
The group is now procuring medical equipment, consumables and generic medications in bulk to cut costs on imported items, Prem Kumar said.
IHH is also planning to consolidate its presence in China, according to Prem Kumar. It turned its clinic business into a profitable operation and is seeing rising number of patients at its hospital in Shanghai. Still, China’s decision to ease restrictions on foreign investment in healthcare sector will not immediately sway IHH into expanding further in the world’s second-largest economy.
“In China, the public sector is a very big competitor to private healthcare,” he said. “We are the only foreign operator in China who has a combination of clinics, and an ecosystem, so we will build on it.”
The company’s priorities also include tapping growing opportunities in existing markets, where it’s already committed to expanding hospital bed capacity by 33% from 2024 through 2028 – a 4,000 bed target.
“There’s no dearth of opportunities in the countries we operate,” he said.
Beyond hospitals
IHH booked RM6.29 billion (US$1.48 billion) in first-quarter revenue, an increase of 5.7% from a year ago.
Its profit slid 33% to RM514 million, which the company attributed to exceptional accounting adjustments.
Singapore, Turkey and Malaysia are currently its main revenue drivers, but the company expects India to become a major contributor in the coming years amid booming demand for private healthcare.
With 35 hospitals, India already has IHH’s biggest in-country network.
Prem Kumar said he was focused on growing out-of-hospital care in IHH’s markets – including ambulatory surgical and care centres, along with primary care centres – to help control cost pressures.
The group currently operates 60 healthcare facilities that aren’t hospitals.
“If we depend on hospitals alone, healthcare costs are going to rise tremendously,” he said.
“Singapore already has such an ecosystem in place while Hong Kong is headed in that direction,” Prem Kumar said.
Still, its home market of Malaysia doesn’t allow hospital operators to also run other healthcare facilities.
IHH plans to make representations to Malaysia’s health ministry in hopes the rule will be changed.
“We definitely want to move, in Malaysia, into the out-of-hospital sector in a big way as well,” he said.
IHH shares have declined 8.4% so far this year, while Malaysia’s benchmark stock index has fallen around 7% amid concerns over US tariffs.